Background: Risk factors for local recurrence after breastconserving treatment of early breast cancer have not previously been evaluated in settings where mammography has been a major pathway to diagnosis of both primary tumour and recurrences, or in patients treated surgically by a formal sector resection.
Introduction
Several retrospective analyses [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] have attempted to identify risk factors for local recurrence after breastconserving treatment for invasive breast cancer. The risk factors identified include the presence of an extensive intraductal component [1] [2] [3] [4] [5] , high histologic grade [3, 4, 6] , high nuclear grade [4] , comedo cancer [3, 4, 7] , lobular cancer [8, 9] , intralymphatic invasion [10] , vascular invasion [4, 11] , young age [10] [11] [12] [13] [14] [15] and tumour size [11, 15] . Only three studies [16] [17] [18] [19] report results from prospective randomised trials. Their findings indicate that low age, the presence of an extensive intraductal component [16] , tumour size [17, 18] and high nuclear grade [16, 18, 19] are statistically significant predictors of local recurrence.
Confounding by indication may hamper the interpretation of retrospective analyses of risk factors for local recurrences in non-trial patients. For example, if wider indications are used to conserve the breast in younger women, or if the excisions are made narrower to ensure a better cosmetic result, a false impression of young age as a risk factor could result. If the histopathological type is allowed to influence the decision to re-excise or to modify radiotherapy, then analyses of histopathological type as a risk factor could be biased. Results derived from patient series in referral hospitals are less likely to be generalizable due to patient selection. Prospective study groups in which specified treatment protocols are followed are needed to test the hypotheses generated in the retrospective studies.
In this study, we have tried to identify risk factors for local recurrence in a population-based randomised trial comparing sector resection of the tumour-containing part of the breast including the underlying pectoral fascia and axillary dissection with (XRT group) or without postoperative radiotherapy (non XRT group) to the breast only in breast cancer stage I. After a median follow-up of five years, 43 women experienced a local recurrence, six of them in the XRT group.
Patient selection
We reviewed the records for all patients with invasive breast cancer in histopathological stage I diagnosed at the participating centres from October 1981 through October 1986. The inclusion criteria were fulfilled by about 50% of all stage I breast cancers. Major reasons for ineligibility were multiple tumours (36%) or undefinable tumour size on mammography (31%). Seventy-four percent of all eligible patients in the defined source population were entered into the trial. There was no evidence of selection bias concerning age and tumour characteristics.
Patients and methods

Study design
The study design has previously been described in detail [20] Women below the age of 80 with a unifocal and mammographically visible breast cancer and a maximal tumour diameter of 20 mm or less on the preoperative mammogram were eligible. All patients were subjected to a standardised sector resection, as previously described [21] , In short, the mammary gland was dissected free to its periphery in the plane of Scarpa's fascia down to the pectoralis muscle, with the pectoral fascia included in the specimen. A full sector of the tumour-containing part of the breast with a 1-2 cm macroscopic lateral margin was resected.
To ensure complete tumour excision, the protocol stipulated penoperative X-ray of the specimen. The axilla was dissected to levels I and II [22] . Patients were eligible for randomisation provided that the specimen was histopathologically free from multifocality in the form of in situ lesions or invasive lesions outside 20 mm from the border of the primary tumour or in the resection margins of the specimen. The axillary nodes should be histopathologically free from metastases. Patients were ineligible if the tumour was transected during surgery. Full informed consent was required. The study was approved by the regional ethics committee
Randomisation
After stratification for participating centre, mode of detection (screening or clinical diagnosis), and mammographic tumour size (equal or less than 10 mm or 11-20 mm), the patients were randomised, either to receive postoperative radiotherapy or surgery alone. Allocation to treatment group was done in blocks of four within each centre and stratum.
Radiotherapy
The radiotherapy technique has previously been described in detail [20] . In short, the breast parenchyma plus 1 cm was defined as the target volume. Two opposing tangential fields with an open angle of 185° were applied. Radiotherapy was delivered by photons from a 4-10 MV linear accelerator or from a M Co unit. A total dose of 54 Gy in 27 fractions was given at the rate of five fractions per week No boost was applied to the tumour bed
Patient accrual
Patient accrual started in October 1981. Six central county hospitals enrolled patients for the study and the last centre entered the trial in May 1985. Patient accrual terminated in September 1988, at which time 389 patients had been included. However, eight were excluded from the analyses due to ineligibility Thus, the trial included 381 patients. Eleven women who did not accept postoperative irradiation were analysed according to the assigned treatment group as were four women who never began this treatment due to complications (postoperative infection, two; cerebrovascular incident, one; and suicide, one).
Evaluation procedures
All slides were re-evaluated by the study pathologist (AL). In order to validate the histopathological classification of tumour type, the slides from one of the participating centres (n = 71) were re-evaluated by a second pathologist (HN). The preoperative mammograms and the perioperative specimen X-rays were re-evaluated by the study mammographer (LT). Both pathologists and the mammographer were blinded to the patient outcome. All patient records were reviewed for identification of patient characteristics, tumour characteristics and events during the primary treatment as shown in Table 1 . The median follow-up was 63 months in the non-XRT group and 65 months in the XRT group. A local recurrence in the breast was defined as any cytologically or histopathologically confirmed invasive or in siru breast cancer in the ipsilateral breast.
Definition of evaluation variables
Patient characteristics (Table 1) Age was analysed as a continuous variable according to the age at the day of operation. Women were considered premenopausal if their last menstruation was <3 months ago, perimenopausal if their last menstruation was >3 months but <5 years ago and postmenopausal if their last menstruation was > 5 years ago. Mode of tumour detection was classified as either screening detected or detected due to the presence of symptoms. A positive family history was defined as havinĝ 1 first degree relative previously treated for breast cancer. (Table 1) Tumours containing intraductal carcinoma both inside and outside the index tumour were classified as positive for extensive intraductal [25] . Nuclear grade was classified as low, medium or high. Vascular invasion was defined as the presence of invasion into the blood and/or lymphatic vessels or not. Resection margins was classified as <5 mm or ^5 mm in the lateral dimension on the histopathological examination Medical records were used to determine whether or not the tumour was palpable at diagnosis. (Table 1) The mammographic appearance of the tumour mass on the preoperative mammogram was classified into five groups according to the appearance of the density (stellate or circular/oval), the presence of microcalcifications (inside or outside the density), and the presence of more than one tumour in the retrospective evaluation (see also Table 3 ). The mammographic parenchymal pattern was classified into five groups on the basis of mammographic anatomic correlation as it appears on the preoperative mammogram [26] . This categorisation is a modification of Wolfe's mammogTaphic parenchymal patterns [27] . The main difference compared with that of Wolfe is the separation into two groups of Wolfe's pattern Nl. This pattern is considered to be a low risk pattern as it represents an entirely normal parenchyma. Our pattern 1 and 2 may be compared with Wolfe's Nl, pattern 3 with Wolfe's PI, pattern 4 with Wolfe's P2 and pattern 5 with Wolfe's DY pattern. Pattern 1 may change into pattern 2 (i.e., entirely fatty) or pattern 3 (i.e., retroareolar linear pattern due to penductal elastosis) during a woman's lifetime.
Histopathological tumour characteristics
Mammographtcal tumour characteristics
Statistical analysis
Risk factors for local recurrence were analysed in univariate and multivariate Cox proportional hazards models [28] . Age (years) and tumour diameter (mm) were kept as continuous variables, while other characteristics were categorised and represented as dummy variables in the analysis In the multivariate analysis age, tumour size, EIC+ and mammographic appearance were introduced stepwise to analyse their influence on the estimate for histopathological type. In all steps radiotherapy and operation year were included and corrected for in the multiple logistic regression by keeping these two characteristics in all models. Non-irradiated patients were the reference group. The estimates obtained in the models are given as relative hazards (RH) with 95% confidence intervals (95% CI). P = 0.05 was considered as the level of statistical significance.
Results
Of the 381 women in the study, 184 were randomly assigned to receive postoperative radiotherapy (XRT group) and 197 to follow-up only (non-XRT group). During the follow-up period, 43 patients experienced a local recurrence; six developed in women assigned to receive radiotherapy. However, two of them had not received such treatment due to postoperative infection and non-compliance, respectively. A third woman developed a local relapse while undergoing radiotherapy which was then discontinued.
At five years the probability of a local recurrence as estimated in life table analyses was 2.3% (95% CI, 0.1%-4.3%) in the XRT group and 18.4% (95% CI, 12.5%-24.2%) in the non-XRT group [29] . The difference was statistically significant {P < 0.0001). The estimated differences between the recurrence rates in the two groups at 5 years was 16.1% (95% CI 8.2%-24.7%). Thirty-three (77%) of all local recurrences occurred within or in the vicinity of the operation field. One of these were in the cuticular scar and two in the skin overlying the operation field. Seven recurrences developed in the breast parenchyma outside the field of surgery and one occurred in an intramammary lymph node. Three recurrences were multifocal. Forty-one were invasive carcinoma and two were in situ carcinomas. (Table 2) There was a 3% (95% CI l%-6%) risk reduction/year of increasing age. This implies that there was a risk reduction of almost 50% with 20 years of increasing age. The only other estimates of relative hazard that approached statistical significance were if the tumour was palpable at diagnosis (P = 0.09) or if the patient was pre-or perimenopausal (P = 0.09). (Table 2) Validation of the histopathology resulted in the same histopathological type in 63 of 71 patients (89%). Presence of the comedo type cancer was strongly associated with an increased risk of a local recurrence compared to that of the tubuloductal and ductal cancers, RH = 3.5 (95% CI 1.8-6.7). 42.4% of the local recurrences occurred in patients operated upon for a comedo cancer. In the XRT group, two of the three patients who experienced a local recurrence after receiving a complete course of radiotherapy had comedo cancers.
Patient characteristics -univariate analysis
Histopathological tumour characteristics -univariate analysis
The lobular type was also associated with a clearly higher risk of local recurrence than that of the tubuloductal and ductal type, RH = 2.8 (95% CI 1.1-7.1). Having a tubular cancer entailed a low RH of 0.2 compared to that of the tubuloductal and ductal cancers. However, the confidence interval was wide and clearly encompassed 1.0. The only other tumour characteristic that approached statistical significance was tumour size (P = 0.09).
Association between histopathological tumour characteristics and age
The prevalence of EIC+ was associated with age < 50 years (P = 0.03) as was the presence of comedo type cancer (P < 0.0001). The ductal and tubulo-ductal type of tumour was associated with an age > 50 years (P = 0.01). Other histopathological types had similar age distributions. (Table 3) There was an increased risk of local recurrence if the tumour on the mammogram appeared as either a circular/oval shaped density without calcifications, RH 2.3 (95% CI 1.1-4.5), or as a stellate lesion with calcifications inside the tumour mass, RH 3.8 (95% CI 1.1-13.0). A trend towards an increased risk of local recurrence with decreased lateral margin on the specimen X-ray was seen (P = 0.2). However, this trend was not linear and was associated with wide confidence intervals. The mammographic pattern on the preoperative mammogram, suspicion of multifocality on the specimen radiography and mammographic tumour size did not show any association with an increased risk of local recurrence.
Mammographical characteristics -univariate analyses
Association between mammographic appearance and histopathological type
The prevalence of comedo carcinomas was statistically significantly associated with a mammographic appearance corresponding to that of a circular/oval shaped density (P = 0.0001). The ductal and tubuloductal type of tumour were however, associated with mammographic appearances other than that of a circular/oval shaped density (P = 0.0002). There was no clear relation between other types of histopathology and the mammographic appearance.
Multivariate analysis (Table 4) A multivariate Cox proportional hazards survival analysis of the risk factors that approached or reached statistical significance in the univariate analysis was also performed (Table 4 ). The evaluation was corrected for treatment group and operation year. Operation-year was taken into account after the finding in our main report [29] of a significant trend of increasing local recurrence rate by year of inclusion in the study. First of all the histopathological type was analysed. Age, tumour size and EIC+ were then introduced stepwise. Comedo cancer was identified as a risk factor elevating the risk about 2.5 times. Lobular cancers showed a similar relative hazard, though the confidence interval was somewhat wider. The introduction of age did not influence the estimates for histopathological type. The estimate for age as an individual risk factor remained the same in the models. Tumour size and EIC+ were not identified as individual risk factors but tended to diminish the importance of comedo-cancers and lobular cancers as individual risk factors. Finally, the mammographic picture was analysed with correction for treatment, operation year, tumour size and histopathologic type. This analysis revealed (data not shown) that only a mammographic appear- Table 4 . Stepwise multivariate Cox proportional hazards survival analysis of patient characteristics and histopathological tumour characteristics as risk factors for local recurrence. In all four models correction for treatment group (radiotherapy/yes vs. no) and operation year was included. ance associated with a stellate lesion with microcalcifications inside the tumour mass remained statistically significant, RH 4.5 (95% CI 1.1-17.6).
Tubuloductal and ductal
Characterisation of a low risk population
Based upon statistically significant risk factors in this study, a Kaplan-Meyer estimate of patients >60 years of age, without comedo or lobular carcinomas in the non-XRT group was performed. Forty percent of the patients in the non-XRT group belonged to this category. The local recurrence rate among these patients was found to be only 5.9% at five years.
Discussion
Within this randomised trial, we were able to identify prognostic factors that possibly can be used in decision making concerning postoperative radiotherapy after breast preserving surgery. If patients with comedo or lobular cancers and/or age under 60 years are excluded, sector resection without radiotherapy can be performed with over 90% local control at five years of follow up. An additional selection criterion which may help selection to radiotherapy is the mammographic appearance: a stellate lesion with microcalcifications inside is a risk factor for local recurrence.
If selective rather than routine use of radiotherapy to the breast after breast conserving surgery was to be employed, this may have important health care implications. E.g., in Sweden today, the current understanding of indications for breast conservation in combination with widespread use of mammography screening means that many centres treat 60%-70% of their breast cancer patients with breast preservation. Routine use of radiotherapy yields a high work load on scarce radiotherapy resources. Additionally, better knowledge about risk factors for local recurrence may help the doctor and the patient to better weigh the arguments and come to rational decisions when pros and cons of radiotherapy are discussed: e.g., long distance from home to the radiotherapy unit, interference with work and social life etc.
The study was population based and the patients were treated at their local hospital rather than being referred to special cancer centres. Both our inclusion criteria and the treatment techniques were uniformly applied. Age or histopathological type were not used to modify the extent of surgery or the dose of radiotherapy. The pathologists who reviewed the slides as well as the mammographer reviewing the mammography's were blinded to the patient's outcome. Thus, there are good reasons to believe that our results are unbiased. However, we studied a limited biological domain: stage I breast cancer with mammographically visible unifocal tumours. So far there are no strong evidence in the literature to suggest that stage of the disease should modify the impact of risk factors for local recurrence, apart from that NSABP researchers found that high nuclear grade was a risk factor in node-positive patients [17] . Our results may therefore well be generalizable to stage II cancers as well. On the other hand, we suspect on theoretical grounds that the results not are generalizable to women with tumours not visible on mammography and mammographically multifocal tumours. These mammographic patterns may be associated with growth patterns with implications for risk of local recurrence [33, 34] .
Several other authors have earlier described young age as a risk factor for local recurrence [10] [11] [12] [13] [14] [15] 19] . Age entailed a 3% decreased risk rate per year of increasing age. This risk reduction implies that a 70-year-old woman has an almost 50% lower risk of local recurrence at five years than a 50-year-old woman. A similar risk reduction was observed by de la Rochefordiere et al., with a reduction of 4% per year of increased age [14] .
The comedo type and lobular type of breast cancer have previously been described as a risk factor for local recurrence [3, 4, [7] [8] [9] . In our study only the comedo type was associated with a statistically significant increased risk in the multivariate model. We found the relative hazard for tubular histological type to be only 0.2.
However, this risk reduction was not statistically significant (P = 0.09).
Presence of an extensive intraductal component (EIC+) has been described as an important risk factor in other studies where local excisions have been performed [1] [2] [3] [4] [5] . In our analysis, however, EIC+ does not seem to play an important role in the risk for local recurrence. Other researchers using a wider resection margin than that achieved by a local excision have also failed to identify EIC+ as an important risk factor for local recurrence [30, 31] . This seems to imply that with greater excision margins the presence of EIC+ is of less importance than the histopathological type and age. This conclusion is supported by Holland et al. observation that the presence of EIC decreased from 79% to 32% at 5 mm and 40 mm, respectively, from the edge of the primary tumour among EIC+ tumours [32] . The corresponding figures among EIC-tumours was 42% and 12%, respectively. Veronesi's finding that EIC+ was a significant risk factor even after quadrantectomy was only analysed univariately [16] . Since our results implicate a strong association between young age and both EIC+ and the comedo type, correction for age and histopathological type might have altered their result. This assumption is supported by comparing the estimates in model 1 and 4 in our Table 4 , and by the fact that Veronesi et al. also found a strong relationship between age < 55 and local recurrence. However, in a metaanalysis of all Milano trials evaluating conservative surgery and radiotherapy, EIC+ was found to be a risk factor for local recurrence also in multivariate analysis [35] . It should also be remembered that the mammographic selection criteria and the definition of EIC+ used in this study may explain the different results between our and other studies regarding EIC+.
Information from the preoperative mammogram has earlier only once been used as a predictor for local recurrence: absence of mammographic nidus and casting calcifications were associated with residual disease after breast conservation with lumpectomy [33] . We found that a circular/oval shaped density was associated with an increased risk of local recurrence in the univariate analysis. When corrected for histopathological type in the multivariate analysis, however, this was no longer a prominent factor, probably explained by the strong association between circular/oval shaped density and the comedo type. The multivariate analysis identified the mammographic appearance of a stellate lesion with microcalcifications inside the tumour as an independent risk factor. Mammographic parenchymal patterns as described by Wolf have been described to help identify patients at high risk of developing breast cancer [36] . However, this has not been widely used in clinical practice since it has been difficult to reproduce [37] . One earlier study found the Dy-pattern to be associated with an increased risk of residual microscopic disease after lumpectomy [33] . However, our attempt in refining the Wolfe pattern did not help identify patients at high risk of local recurrence.
The trend towards a higher risk of local recurrence with a decreased lateral margin on the perioperative X-ray is compatible with the suggestion made by Holland et al. [32] that adequate margins are important.
When we tried to identify a low risk population, we did not attempt to optimise the best predictive model in this particular study, as local recurrences have so far been relatively few. The formulation of a decision model whether or not to use postoperative radiotherapy requires not only a validation of our results in other materials but also a broader analysis of the costs and benefits of routine postoperative radiotherapy after breast conserving surgery. A cost-effectiveness analysis based on the results of this risk factor analysis showed that routine postoperative radiotherapy in a five-year perspective is expensive, particularly in the low-risk group. The cost/prevented local recurrence in this subgroup was estimated to ~ 1 200 000 SEK (~ £ 115000) [38] .
